Top-News
Pharmazeutika USA

Zevra Therapeutics Inc Aktie

Aktie
WKN:  A2QLX7 ISIN:  US4884452065 US-Symbol:  ZVRA
8,75 €
-0,45 €
-4,89%
21.11.24
Handeln Depot/Watchlist
Aktienanzahl *
43,43 Mio.
Marktkapitalisierung *
378,49 Mio. €
Streubesitz
72,02%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 10.04.2024

Zevra Therapeutics Inc News

18.06.24 - PR Newswire
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders PR Newswire
11.05.24 - Small- & Micro Cap Investment
Analyse mit hohem Kursziel für NurExone Biologic Inc.
Im Biotech-​Bereich gibt es auch nach der Ära der Corona-​Hot-Stocks noch sehr aussichtsreiche Aktien. Dazu zählen aktuell klar Viking Therapeutics Inc. (ISIN: US92686J1060) und ...
06.05.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PR Newswire
28.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PR Newswire
28.04.24 - Small- & Micro Cap Investment
Das nächste Viking Therapeutics? NurExone-Aktie laut Analysten-Report mit über 400% Kurspotenzial
Im Biotech-​Bereich gibt es auch nach der Ära der Corona-​Hot-Stocks noch sehr aussichtsreiche Aktien. Dazu zählen aktuell klar Viking Therapeutics Inc. (ISIN: US92686J1060) und ...
20.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PR Newswire
12.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PR Newswire
04.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PR Newswire
21.07.21 - PR Newswire
Thinking about buying stock in Marathon Digital, Riot Blockchain, KemPharm, Powerbridge Technologies, or LightPath Technologies?
Thinking about buying stock in Marathon Digital, Riot Blockchain, KemPharm, Powerbridge Technologies, or LightPath Technologies? PR Newswire
05.03.21 - PR Newswire
Thinking about buying stock in Humanigen, Marathon Oil, KemPharm, GoHealth, or SRAX Inc?
Thinking about buying stock in Humanigen, Marathon Oil, KemPharm, GoHealth, or SRAX Inc? PR Newswire
03.03.21 - PR Newswire
Thinking about buying stock in Ovid Therapeutics, KemPharm, Super League Gaming, Heat Biologics, or TherapeuticsMD?
Thinking about buying stock in Ovid Therapeutics, KemPharm, Super League Gaming, Heat Biologics, or TherapeuticsMD? PR Newswire
01.03.21 - PR Newswire
Thinking about buying stock in Phio Pharmaceuticals, SRAX Inc, KemPharm, Avadel Pharmaceuticals, or Neovasc Inc?
Thinking about buying stock in Phio Pharmaceuticals, SRAX Inc, KemPharm, Avadel Pharmaceuticals, or Neovasc Inc? PR Newswire
16.02.21 - PR Newswire
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences? PR Newswire
04.12.18 - PR Newswire
Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th
Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th PR Newswire
03.12.18 - PR Newswire
KemPharm to Webcast Live at VirtualInvestorConferences.com on December 6th
KemPharm to Webcast Live at VirtualInvestorConferences.com on December 6th PR Newswire
03.02.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio Corporati
Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, ...
23.01.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KemPharm, Inc. - KMPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KemPharm, Inc. - KMPH PR Newswire
23.01.17 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of KemPharm, Inc. (KMPH)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of KemPharm, Inc. (KMPH) PR Newswire
20.01.17 - PR Newswire
KEMPHARM NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Significant Losses Investing In KemPharm, Inc. To Contact The Firm
KEMPHARM NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Significant Losses Investing In KemPharm, Inc. To Contact The Firm PR Newswire
01.11.16 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of KemPharm, Inc. (KMPH)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of KemPharm, Inc. (KMPH) PR Newswire

Newssuche

Videos

22.11.24
Technical Trading: Kaffee Short Chance
Kaffee Short Typ: Turbo Open End WKN: VC8QTD Hebel: 5,27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »